JAMA February 2025 PMID 39616604

Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel.

Rajesh T Gandhi, Raphael J Landovitz, Paul E Sax, Davey M Smith, Sandra A Springer, Huldrych F Günthard, Melanie A Thompson, Roger J Bedimo, Constance A Benson, Susan P Buchbinder, Brenda E Crabtree-Ramirez, Carlos Del Rio, Ellen F Eaton, Joseph J Eron, Jennifer F Hoy

Full text PDF Download social card

Mentions

196

Peak: 115 in Dec 2024

across 6 sources since Dec 2024

Extended reach

1,391,150

potential audience

Total likes

440

Video views

2,301

Mentions per month

Dec 2024 – Oct 2025

Where it's discussed

X / Twitter163 posts
News21 articles
Bluesky4 posts
Facebook3 posts
Blogs3 articles
YouTube2 videos

AI synopsis

What people are saying

The discussions prominently feature links to the publication and reiterate its essential recommendations, such as the use of integrase strand transfer inhibitors and the necessity for early access to treatment. Phrases like 'updated recommendations' and 'highly relevant' are used to underscore the importance of these guidelines, while expressions of hope for ending the HIV pandemic reflect a tone of urgency and optimism, contributing to the overall positive sentiment.

AgreementModerate agreement

Most posts indicate a general support for the updated recommendations in the publication, with many expressing approval of the advances in HIV treatment.

InterestHigh interest

The posts exhibit a high level of curiosity and relevance, as many participants are eager to discuss the updates and share links to the guidelines.

EngagementModerate engagement

While many posts provide information and link to the publication, they lack deeper personal commentary or nuanced debate, indicating a moderate level of engagement.

ImpactHigh impact

Users perceive the publication as having a significant influence on HIV treatment and prevention strategies, reflecting a belief that these recommendations will shape future clinical practice.

Abstract in brief

The text emphasizes that new antiretroviral drugs and formulations are continuously being developed for HIV prevention and treatment, highlighting the importance of updated strategies to manage the virus effectively.
A panel of expert physician scientists has compiled updated recommendations for 2024 based on extensive literature reviews and data from scientific conferences, focusing on treatment protocols tailored to specific patient needs.
Current recommendations advocate for antiretroviral therapy for all individuals with HIV, primarily using integrase strand transfer inhibitors, while also offering alternatives for those with unique circumstances, and suggesting both oral and injectable options for HIV prevention.

Read the full abstract

All mentions

Updated Recommendations for HIV Treatment and Prevention 2024

New antiretroviral drugs and formulations are continuously developed for HIV prevention and management. This video features Dr. Rajesh T. Gandhi discussing updated strategies and recommendations for treating HIV…

JAMA Network · Dec 5, 2024 2,300 views

2024 HIV Treatment and Prevention Recommendations Explained

This video presents updated recommendations for HIV treatment and prevention. New antiretroviral drugs are continuously developed to tailor treatment protocols to specific patient needs, emphasizing the use of integrase…

Francisco Coronado · Oct 9, 2025 2 views

Levi Hernandez

@levi_hdez · X

RT @INCMNSZ_DirInv: Estudio internacional que proporciona recomendaciones actualizadas para el tratamiento y el manejo clínico del VIH y su…

Feb 25, 2025 · 16 shares · 681 followers View post →

N und Auto

@naoto140 · X

https://t.co/SniRcbBY86

Feb 24, 2025 · 6 followers View post →

jim

@JimMea · X

JAMA Feb 18 2025; Antiretroviral drugs for treatment and prevention of HIV in adults: 2024 recommendations of the international antiviral Society – USA panel . Rajesh T Gandhi et al. https://t.co/zWweV5RNmz

Feb 24, 2025 · 1 like · 1,550 followers View post →

Jean Gajardo

@jean_gajardo · X

RT @JAMA_current: This Special Communication from @IAS_USA provides updated 2024 recommendations for HIV treatment and clinical management…

Feb 23, 2025 · 7 shares · 1,140 followers View post →

Brock E. Polnaszek MD MPH(c)

@BPolnaszek · X

RT @JAMA_current: This Special Communication from @IAS_USA provides updated 2024 recommendations for HIV treatment and clinical management…

Feb 23, 2025 · 7 shares · 481 followers View post →

Bailey Nelsons

@Baileybillyb · X

RT @JAMA_current: This Special Communication from @IAS_USA provides updated 2024 recommendations for HIV treatment and clinical management…

Feb 23, 2025 · 7 shares · 284 followers View post →

Alexandre R. Marra

@alexmarra73 · X

RT @JAMA_current: This Special Communication from @IAS_USA provides updated 2024 recommendations for HIV treatment and clinical management…

Feb 23, 2025 · 7 shares · 144 followers View post →

gabafeitina

@gabrielbasto_ · X

RT @JAMA_current: This Special Communication from @IAS_USA provides updated 2024 recommendations for HIV treatment and clinical management…

Feb 23, 2025 · 7 shares · 100 followers View post →

JAMA

@JAMA_current · X

This Special Communication from @IAS_USA provides updated 2024 recommendations for HIV treatment and clinical management and HIV prevention. https://t.co/PDpraD4irB https://t.co/ghG2YWjMPg

Feb 23, 2025 · 20 likes · 7 shares · 488,639 followers View post →

Un1v3rs0 Z3r0

@Un1v3rs0Z3r0 · X

IAS-USA Recommendations: Antiretrovirals for Treatment and Prevention of HIV in Adults https://t.co/6u7V49vgna

Feb 18, 2025 · 508 followers View post →

Mª Dolores Díaz

@mdialop1 · X

RT @jbb4jbb4: IAS-USA Recommendations: Antiretrovirals for Treatment and Prevention of HIV in Adults https://t.co/w7RONEUj7Y

Feb 10, 2025 · 5 shares · 114 followers View post →

Peeref

@Peeref1 · X

Feb 5, 2025 · 170 followers View post →

S Medrano

@drsmedrano · X